JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES) ›› 2014, Vol. 52 ›› Issue (10): 49-54.doi: 10.6040/j.issn.1671-7554.0.2014.279

Previous Articles     Next Articles

Correlation of serum IMD, CysC and FGF23 with atherosclerosis in essential hypertensive

LI Jing, XU Tongtong, YU Fan   

  1. Department of Cardiology, Affiliated Hospital of Guilin Medical College, Guilin 541001, Guangxi, China
  • Received:2014-04-29 Revised:2014-06-23 Online:2014-10-10 Published:2014-10-10

PDF (PC)

217

Abstract: Objective To analyze the association between serum intermedin (IMD), Cystatin C (CysC) and fibroblast growth factor 23 (FGF23) with atherosclerosis (AS) in essential hypertensive (EH). Methods Serum IMD, CysC and FGF23 levels of 60 patients with EH (EH group) and 60 healthy subjects (control group) were detected with enzyme-linked immunosorbent assay (ELISA). The carotid intima media thickness (cIMT) was measured with UCG. Results The cIMT, serum IMD, CysC and FGF23 levels were significantly higher in EH group than in control group (P<0.05). In EH patients, cIMT, serum IMD, CysC and FGF23 levels increased with elevated blood pressure levels (P<0.05). Based on the level of cIMT, all subjects were divided into normal cIMT group, thickened cIMT group and mottling formation group. The serum IMD, CysC and FGF23 levels in the three groups rose with cIMT, and the difference had statistical significance (P<0.001). The cIMT level was positively correlated with serum IMD, CysC and FGF23 levels (r=0.770, 0.616, 0.822; P<0.001). When cIMT level was taken as the dependent variable, unconditioned Logistic regression analysis showed that SBP, IMD, CysC, FGF23, and HDL were independent risk factors forcIMT (OR=1.104, 1.120, 1.107, 1.069, 3.592; P<0.05). Conclusion Serum IMD, CysC and FGF23 levels are closely associated with blood pressure classification and cIMT, indicating that they are independent risk factors of cIMT. They may participate in the pathogenesis of EH and affect the process of AS. Combined-detection of serum IMD, CysC and FGF23 can reflect the severity of AS and provide a new approach for its prevention and treatment.

Key words: Intermedin, Fibroblast growth factor 23, Hypertension, Cystatin C, Atherosclerosis

CLC Number: 

  • R544.11
[1] 中国高血压防治指南修订委员会.中国高血压防治指南2010[J].中华高血压杂志, 2011, 19(8):701-743. The rebision committee for China's prevention and cure guide of hypertension. Hypertension Prevention and Cure Guideline of China 2010[J]. Chinese Journal of Hypertension, 2011, 19(8):701-743.
[2] Stein J H, Korcarz C E, Post W S, et al. Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk:summary and discussion of the American society of echocardiography consensus statement[J]. Prev Cardiol, 2009, 12(1):34-38.
[3] Stein J H, Korcarz C E, Hurst R T, et al. Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk:a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force[J]. J Am Soc Echocardiogr, 2008, 21(2):93-111.
[4] Sibal L, Agarwal S C, Home P D. Carotid intima-media thickness as a surrogate marker of cardiovascular disease in diabetes[J]. Diabetes Metab Syndr Obes, 2011, 19(4):23-34.
[5] Roh J, Chang C L, Bhalla A, et al. Intermedin is a calcitonin/calcitonin generelated peptide family peptide acting through the calcitonin receptor-like receptor/receptor activity-modifying protein receptor complexes[J]. J Biol Chem, 2004, 279(8):7264-7274.
[6] Pan C S, Yang J H, Cai D Y, et al. Cardiovascular effects of newly discovered peptide intermedin/adrenomedullin 2[J]. Peptides, 2005, 26(9):1640-1646.
[7] Fujisawa Y, Nagai Y, Miyatake A, et al. Effects of adrenomedullin 2 on regional hemodynamics in conscious rats[J]. Eur J Pharmacol, 2007, 558(1-3):128-132.
[8] Anastasi A, Brown M A, Kembhavi A A, et al. Cystatin, a protein inhibitor of cysteine proteinases. Improved purification from egg white, characterization, and detection in chicken serum[J]. Biochem J, 1983, 211(1):129-138.
[9] Kestenbaum B, Rudser K D, de Boer I H, et al. Differences in kidney function and incident hypertension:the multiethnic study of atherosclerosis[J]. Ann Intern Med, 2008, 148(7):501-508.
[10] 刘亚普, 张新梅, 王美玲, 等. 高血压患者外周血胱抑素C水平的检测[J]. 国际检验医学杂志, 2013, 34(4):468-469. LIU Yapu, ZHANG Xinmei, WANG Meiling, et al. The detection of peripheral blood cystatin C level in hypertensive[J]. International Journal of Laboratory Medicine, 2013, 34(1):468-469.
[11] Luc G, Bard J M, Lesueur C, et al. Plasma cystatin-C and development of coronary heart disease:The PRIME Study[J]. Atherosclerosis, 2006, 185(2):375-380.
[12] Choe J Y, Park S H, Kim S K. Serum cystatin C is a potential endogenous marker for the estimation of renal function in male gout patients with renal impairment[J]. J Korean Med Sci, 2010, 25(1):42-48.
[13] 黄冠华, 孙刚, 闫旭龙. 胱抑素C、颈动脉内膜中层厚度与冠心病的关系[J]. 临床心血管病杂志, 2013, 29(7):547-548. HUANG Guanhua, SUN Gang, YAN Xulong. The relationship between CystatinC, carotid intima media thickness and coronary heart disease[J]. J Clin Cardiol, 2013, 29(7):547-548.
[14] Komaba H, Fukagawa M. FGF23-parathyroid interaction:implications in chronic kidney disease[J]. Kidney Int, 2010, 77(4):292-298.
[15] Yilmaz M I, Sonmez A, Saglam M, et al. FGF-23 and vascular dysfunction in patients with stage 3 and 4 chronic kidney disease[J]. Kidney Int, 2010, 78(7):679-685.
[16] Sigala F, Savvari P, Liontos M, et al. Increased expression of bFGF is associated with carotid atherosclerotic plaques instability engaging the NF-kappaB pathway[J]. J Cell Mol Med, 2010, 14(9):2273-2280.
[1] WUYi-Na, GE Zhi-Ming, LI Fang, HE Hong, JIANG Hong, ZHANG Yun. Expressions of angiotensin converting enzyme 2 mRNA and protein in the kidneys in spontaneously hypertensive rats [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2209, 47(6): 5-.
[2] FU Jieqi, ZHANG Man, ZHANG Xiaolu, LI Hui, CHEN Hong. Molecular mechanism of Toll-like receptor 4 in the aggravation of blood lipid accumulation by inhibiting the peroxisome proliferator-activate receptor γ [J]. Journal of Shandong University (Health Sciences), 2020, 1(7): 24-31.
[3] DU Futian, DU Yunlong, LIN Hongfeng. A clinical research on occlusive techniques for partial splentic embolization combined with radiofrequency ablation for hypersplenism due to portal hypertension [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(7): 79-83.
[4] YIN Ni, YANG Guanlin, JIANG Junwen, WANG Chuntian, WANG Fengyao, JIA Lianqun, GAO Xiaoyu, PAN Jiaxiang, LI Qin, LI Jia, FENG Yuanjie, GAO Yuzhu, ZHOU He, ZHANG Zhe. A reliable system to assess atherosclerosis model of Bama minipigs [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(7): 1-5.
[5] YU Tao, LIU Huanle, FENG Xin, XU Fuyin, CHEN Yafei, XUE Fuzhong, ZHANG Chengqi. A hypertension risk prediction model based on health management cohort [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(6): 61-65.
[6] YAN Fangying, SHAN Xiaolan, LI Jingyuan, ZHANG Jie, YAN Xuefang, YANG Yi, BU Peili. Pioglitazone ameliorates cardiac fibrosis induced by hypertension via regulating Sirt3 [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(5): 13-18.
[7] ZHANG Luan, CHEN Ou, LUAN Yun, ZHU Xiaobo, CHEN Yuan, WANG Yibiao. Effects of gemigliptin on the therapeutic effect and inflammatory factors of monocrotaline-induced pulmonary arterial hypertension in rats [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(5): 19-22.
[8] LI Rui, MA Weihong, REN Manyi, ZHAO Mengmeng, JIANG Shan, JU Yuanyuan, GUO Ying, SUN Zhaohui, SUI Shujian. Correlation between TWEAK and cardiac remodeling in essential hypertensive patients [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(5): 49-55.
[9] ZHANG Hua, ZHUANG Xia, LIU Zhendong, DIAO Yutao, DU Jiachen, CUI Yi. Evaluation of the effects of high blood pressure on white matter lesion in young adults using diffusion tensor imaging [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(5): 56-60.
[10] WEI Dandan, ZHANG Cheng. Effects of the overexpression of type 4 angiotensin receptor on the formation of atherosclerotic lesions [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(8): 1-5.
[11] XU Tianyi, WU Ping, WANG Ailing, CHEN Liping. Clinical effect of milrinone atomization inhalation on treating severe pneumonia complicated with heart failure of neonates and infants [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(7): 88-90.
[12] WANG Dan, QI Hengtao, SUN Shuzhen. Changes of carotid artery structure and function in children with primary nephrotic syndrome [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(5): 88-91.
[13] SUN Pengfei, MENG Xiao, ZHANG Kai, LI Li. The effect of resistin-like molecule β on the vulnerability of atherosclerotic plaques in ApoE-/- mice [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(3): 1-4.
[14] WANG Lixuan, ZHANG Lu, XU Xin, LI Sixue, LIU Min, WANG Yaping, MA Huijuan. Chronic intermittent hypobaric hypoxia enhances the vasodilatation of thoracic aorta via PI3K-dependent eNOS activation in rats [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(2): 11-15.
[15] PAN Yanyan, SUN Yongchao, ZHAO Cuifen, KONG Qingyu. Clinical efficacy of bosentan in the treatment of babies with congenital heart disease complicated with pulmonary hypertension [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(2): 53-56.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Copyright 2018 © Editorial office of Journal of Shandong University (Health Sciences)
Supported by Beijing Magtech Co.Ltd